49 101 ved baseline) til endpoint (de gennemsnitlige ændringer var henholdsvis - 22, 57, - 26, 32, - 22, 49) ved hver dosis ZYPADHERA (405 mg hver 4. uge, 300 mg hver 2. uge og 210 mg hver 2. uge) sammenlignet med placebo (gennemsnitændring - 8, 51).
Total Positive and Negative Symptom Scores (PANSS) showed significant improvement from baseline (baseline mean Total PANSS Score 101) to endpoint (mean changes -22.57, -26.32, -22.49 respectively) with each dose of ZYPADHERA (405 mg every 4 weeks, 300 mg every 2 weeks, and 210 mg every 2 weeks) as compared to placebo (mean change -8.51).